Search icon

FREZENT BIOLOGICAL SOLUTIONS INC.

Company claim

Is this your business?

Get access!

Company Details

Name: FREZENT BIOLOGICAL SOLUTIONS INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 06 Mar 2017 (8 years ago)
Entity Number: 5096810
ZIP code: 12207
County: New York
Place of Formation: Delaware
Foreign Legal Name: FREZENT BIOLOGICAL SOLUTIONS INC.
Address: 418 BROADWAY, STE R, ALBANY, NY, United States, 12207
Principal Address: 269 West 71 street, basement, New Yrok, NY, United States, 10023

DOS Process Agent

Name Role Address
REGISTERED AGENTS INC. DOS Process Agent 418 BROADWAY, STE R, ALBANY, NY, United States, 12207

Chief Executive Officer

Name Role Address
NATASHA SHTRAIZENT Chief Executive Officer 269 WEST 71 STREET, BASEMENT, NEW YORK, NY, United States, 10023

U.S. Small Business Administration Profile

Phone Number:
E-mail Address:
Contact Person:
NATASHA SHTRAIZENT
Ownership and Self-Certifications:
Women-Owned Small Business, Woman Owned
User ID:
P2781760

Commercial and government entity program

CAGE number:
7WWH8
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2025-04-08
CAGE Expiration:
2030-04-08
SAM Expiration:
2026-04-04

Contact Information

POC:
NATASHA SHTRAIZENT

History

Start date End date Type Value
2025-03-02 2025-03-02 Address 269 WEST 71 STREET, BASEMENT, NEW YORK, NY, 10023, USA (Type of address: Chief Executive Officer)
2023-08-02 2025-03-02 Address 269 WEST 71 STREET, BASEMENT, NEW YORK, NY, 10023, USA (Type of address: Chief Executive Officer)
2023-08-02 2025-03-02 Address 418 BROADWAY, STE R, ALBANY, NY, 12207, USA (Type of address: Service of Process)
2022-09-29 2023-08-02 Address 418 BROADWAY, STE R, ALBANY, NY, 12207, USA (Type of address: Service of Process)
2022-03-15 2022-09-29 Address 90 STATE STREET, STE 700 OFFICE 40, ALBANY, NY, 12207, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
250302022245 2025-03-02 BIENNIAL STATEMENT 2025-03-02
230802003782 2023-08-02 BIENNIAL STATEMENT 2023-03-01
220929007734 2022-09-29 CERTIFICATE OF CHANGE BY AGENT 2022-09-29
220315001542 2022-03-14 CERTIFICATE OF AMENDMENT 2022-03-14
170306000461 2017-03-06 APPLICATION OF AUTHORITY 2017-03-06

USAspending Awards / Financial Assistance

Date:
2021-02-08
Awarding Agency Name:
National Science Foundation
Transaction Description:
SBIR PHASE I: DEVELOPMENT OF A NOVEL PEPTIDE INHIBITOR OF CORONAVIRUS PAPAIN-LIKE PROTEASE AS A PROPHYLACTIC AND ANTI-VIRAL THERAPEUTIC FOR COVID19, ADMINISTERED BY INHALATION
Obligated Amount:
255981.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 24 Mar 2025

Sources: New York Secretary of State